Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | membrane metallo-endopeptidase-like 1 | Starlite/ChEMBL | No references |
Homo sapiens | membrane metallo-endopeptidase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.6994 | 0.6859 |
Loa Loa (eye worm) | hypothetical protein | 0.0228 | 1 | 1 |
Schistosoma mansoni | endothelin-converting enzyme-like 1 (damage-induced neuronal endopeptidase) | 0.0056 | 0.0665 | 0.0247 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.006 | 0.088 | 0.0471 |
Toxoplasma gondii | peptidase family M13 protein | 0.0228 | 1 | 0.5 |
Schistosoma mansoni | family M13 non-peptidase homologue (M13 family) | 0.0115 | 0.3886 | 0.3612 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.6779 | 0.6635 |
Schistosoma mansoni | hypothetical protein | 0.006 | 0.088 | 0.0471 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.0115 | 0.3886 | 0.3612 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.0115 | 0.3886 | 0.3612 |
Mycobacterium leprae | probable zinc metalloprotease | 0.0228 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.6994 | 0.6859 |
Schistosoma mansoni | family M13 non-peptidase homologue (M13 family) | 0.0056 | 0.0665 | 0.0247 |
Loa Loa (eye worm) | hypothetical protein | 0.0228 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.006 | 0.088 | 0.0471 |
Loa Loa (eye worm) | peptidase family M13 containing protein | 0.0169 | 0.6779 | 0.6635 |
Brugia malayi | Hypothetical zinc metalloproteinase T16A9.4 | 0.0228 | 1 | 1 |
Schistosoma mansoni | neprilysin-2 (M13 family) | 0.0115 | 0.3886 | 0.3612 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.0228 | 1 | 1 |
Mycobacterium tuberculosis | Probable zinc metalloprotease Zmp1 | 0.0228 | 1 | 1 |
Loa Loa (eye worm) | peptidase family M13 containing protein | 0.0169 | 0.6779 | 0.6635 |
Schistosoma mansoni | endothelin-converting enzyme-related | 0.0056 | 0.0665 | 0.0247 |
Echinococcus multilocularis | Metazoa galactosyltransferase | 0.0051 | 0.0429 | 0.0429 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.6779 | 0.6635 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.0056 | 0.0665 | 0.0247 |
Schistosoma mansoni | hypothetical protein | 0.006 | 0.088 | 0.0471 |
Echinococcus granulosus | endothelin converting enzyme 1 | 0.0228 | 1 | 1 |
Brugia malayi | peptidase family M13 containing protein | 0.0056 | 0.0665 | 0.0247 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.0056 | 0.0665 | 0.0247 |
Schistosoma mansoni | hypothetical protein | 0.006 | 0.088 | 0.0471 |
Loa Loa (eye worm) | zinc metallopeptidase 4 | 0.0056 | 0.0665 | 0.0247 |
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.6994 | 0.6859 |
Schistosoma mansoni | hypothetical protein | 0.006 | 0.088 | 0.0471 |
Loa Loa (eye worm) | hypothetical protein | 0.0113 | 0.3773 | 0.3494 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.0056 | 0.0665 | 0.0247 |
Mycobacterium ulcerans | zinc metalloprotease | 0.0228 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.006 | 0.088 | 0.0471 |
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.6994 | 0.6859 |
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.6994 | 0.6859 |
Loa Loa (eye worm) | hypothetical protein | 0.0228 | 1 | 1 |
Schistosoma mansoni | Nep2 peptidase (M13 family) | 0.0115 | 0.3886 | 0.3612 |
Echinococcus multilocularis | endothelin converting enzyme 1 | 0.0228 | 1 | 1 |
Onchocerca volvulus | 0.0113 | 0.3773 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.6779 | 0.6635 |
Schistosoma mansoni | neprilysin | 0.006 | 0.088 | 0.0471 |
Loa Loa (eye worm) | hypothetical protein | 0.0173 | 0.6994 | 0.6859 |
Loa Loa (eye worm) | hypothetical protein | 0.0169 | 0.6779 | 0.6635 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 7.3 nM | BindingDB_Patents: Inhibition Assay. Recombinant human neutral endopeptidase (expressed in insect cells and purified using standard methods, final concentration 7 µM) is pre-incubated with test compounds at various concentrations for 1 hour at room temperature in 10 mM sodium phosphate buffer at pH 7.4, containing 150 mM NaCl and 0.05% (w/v) CHAPS. The enzymatic reaction is started by the addition of a synthetic peptide substrate Cys(PT14)-Arg-Arg-Leu-Trp-OH to a final concentration of 0.7 µM. Substrate hydrolysis leads to an increase fluorescence lifetime (FLT) of PT14 measured by the means of a FLT reader as described by Doering et al. (2009). The effect of the compound on the enzymatic activity was determined after 1 hour (t=60 min) incubation at room temperature. | ChEMBL. | No reference |
IC50 (binding) | = 7.3 nM | BindingDB_Patents: Fluorescence Lifetime-Based Assay. See A fluorescence lifetime-based assay for protease inhibitor profiling on human kallikrein 7 Doering K, Meder G, Hinnenberger M, Woelcke J, Mayr L M, Hassiepen U Biomol Screen. 2009 January; 14(1):1-9. Recombinant human neutral endopeptidase (expressed in insect cells and purified using standard methods, final concentration 7 pM) is pre-incubated with test compounds at various concentrations for 1 hour at room temperature in 10 mM sodium phosphate buffer at pH 7.4, containing 150 mM NaCl and 0.05% (w/v) CHAPS. The enzymatic reaction is started by the addition of a synthetic peptide substrate Cys(PT14)-Arg-Arg-Leu-Trp-OH to a final concentration of 0.7 µM. Substrate hydrolysis leads to an increase fluorescence lifetime (FLT) of PT14 measured by the means of a FLT reader as described by Doering et al. (2009). The effect of the compound on the enzymatic activity was determined after 1 hour (t=60 min) incubation at room temperature. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.